Immunic, Inc. is trading 5.3% down today at $11.61 as a broad risk-off environment pressures high-beta, small-cap biotech stocks.
- The decline extends a sharp pullback from early-June highs following a brief technical rebound on June 9.
- With no company-specific news or rating changes, the move aligns with major U.S. indices falling more than 1%.
- Immunic, Inc. is facing increased volatility as investors pull back from riskier assets in the current market environment.